AIM
VNDA icon

Aigen Investment Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Aigen Investment Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,597
Closed -$47.7K – 1035
2024
Q1 		$47.7K Buy
+11,597
New +$46.4K 0.01% 632
2020
Q2 		– Sell
-13,626
Closed -$141K – 1316
2020
Q1 		$141K Sell
13,626
-39,122
-74% -$485K 0.02% 801
2019
Q4 		$866K Buy
+52,748
New +$798K 0.14% 210

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aigen Investment Management's VNDA Position: Q2 2024 in Review

Aigen Investment Management sold out of Vanda Pharmaceuticals (VNDA) in Q2 2024, closing a stake of 11,597 shares — an estimated $47.7K sold.

Aigen Investment Management first reported a position in VNDA in Q4 2019 and held it in 3 quarters. The position peaked at $866K in Q4 2019. 148 funds tracked by Wall St. Rank hold VNDA as of Q2 2024.

  • Aigen Investment Management reported no remaining Vanda Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Aigen Investment Management sold 11,597 Vanda Pharmaceuticals shares in Q2 2024, an estimated $47.7K.
  • Aigen Investment Management first reported a position in Vanda Pharmaceuticals in Q4 2019 and held it in 3 quarters.
  • Aigen Investment Management's Vanda Pharmaceuticals position peaked at $866K in Q4 2019.
  • 148 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2024.

Based on Aigen Investment Management's 13F filing for Q2 2024, filed 9 Aug 2024.